Panacea Biotec reports standalone net loss of Rs 6.85 crore in the September 2022 quarter
Sales decline 59.13% to Rs 48.74 crore
Net Loss of Panacea Biotec reported to Rs 6.85 crore in the quarter ended September 2022 as against net loss of Rs 22.37 crore during the previous quarter ended September 2021. Sales declined 59.13% to Rs 48.74 crore in the quarter ended September 2022 as against Rs 119.26 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales48.74119.26 -59 OPM %-12.97-14.63 -PBDT-0.61-15.89 96 PBT-6.85-22.37 69 NP-6.85-22.37 69Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2022 | 5:13 PM IST